Soluble mediators in anti-fungal immunity.


Journal

Current opinion in microbiology
ISSN: 1879-0364
Titre abrégé: Curr Opin Microbiol
Pays: England
ID NLM: 9815056

Informations de publication

Date de publication:
12 2020
Historique:
received: 03 04 2020
revised: 11 05 2020
accepted: 13 05 2020
pubmed: 1 7 2020
medline: 25 5 2021
entrez: 1 7 2020
Statut: ppublish

Résumé

Although soluble mediators of our innate immune system have a substantial impact on invading microbes, their role against fungal pathogens has been underexplored. Constituting the humoral immunity, soluble mediators comprise the complement system, collectins, acute-phase proteins, antibodies and antimicrobial peptides. These components can prevent fungal infection either by directly interacting with invading microbes, leading to their aggregation (microbistatic), destruction (microbicidal) or linking them to cellular immunity. The composition of soluble-mediator varies with human body-fluids, resulting in different antifungal mechanisms. Moreover, cellular immune system deploys both oxidative and non-oxidative mechanisms to destroy extracellular or internalized fungal pathogens; however, cellular immune activation is mainly influenced as well as regulated by soluble mediators. This review outlines the antifungal mechanism employed, directly or indirectly, by soluble mediators, and in response, the evading strategies of the fungal pathogens.

Identifiants

pubmed: 32604018
pii: S1369-5274(20)30065-5
doi: 10.1016/j.mib.2020.05.005
pii:
doi:

Substances chimiques

Complement System Proteins 9007-36-7

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

24-31

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Sarah Dellière (S)

Institut Pasteur, Molecular Mycology Unit, UMR2000, CNRS, Paris, France; Parasitology-Mycoloy Laboratory, Groupe Hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance Publique-Hôpitaux de Paris, Université de Paris, Paris, France.

Sarah Sze Wah Wong (S)

Institut Pasteur, Molecular Mycology Unit, UMR2000, CNRS, Paris, France.

Vishukumar Aimanianda (V)

Institut Pasteur, Molecular Mycology Unit, UMR2000, CNRS, Paris, France. Electronic address: vkumar@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH